About PHARMAQ
PHARMAQ is an Agriculture company based in Norway founded in 1999, and was acquired by Permira in June 2013. Vaccines and medicines for animals are manufactured. It operates on a Professional Services and Direct-to-Consumer (D2C) model in Agriculture, Healthcare, and Energy & Utilities sectors. The company has 14 employees. Its chief executive, as recorded, is Morten Nordstad. PHARMAQ offers products and services including Vaccines and Therapeutics, Vaccination Equipment, and Diagnostics & Advice. Its focus areas include Veterinary Medicine and Aquaculture Health. Its legal entity is PHARMAQ AS.
Company details
PHARMAQ is established as a global leader in the development of vaccines and health solutions for the aquaculture industry. The company is focused on providing environmentally sound and effective products through dedicated research. Operations are centered in Norway, with subsidiaries across multiple continents including Europe, North and South America, and Asia. Solutions are tailored for various fish species such as salmonids, tilapia, and sea bass. The commitment to sustainability and innovation in fish health is supported by a workforce of approximately 420 employees.
- Headquarters Norway
- Employees 14
- Stage Acquired
- SectorsAgricultureHealthcare Energy & Utilities
- Email••••••••
- Phone•••• ••••
- Website pharmaq.com/en
- Social LinkedIn
- Acquired by Permira (Jun 2013)
- Legal Name Pharmaq As
Products & Services of PHARMAQ
PHARMAQ offers a comprehensive portfolio of products and services, including Vaccines and Therapeutics, Vaccination Equipment, and Diagnostics & Advice.
Vaccines are developed for fish health in aquaculture.
Equipment is provided for efficient fish vaccination processes.
Analysis and advice are offered for fish welfare.
Funding Insights of PHARMAQ
- Total Rounds 1
- Last Round Grant — $53,116
- First Round $53,116
(Jan 2019)
- Investors Count 1
All 1 funding rounds of PHARMAQ with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $53,116 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in PHARMAQ
PHARMAQ has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Permira and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in technology, consumer, healthcare, and service sectors. | 1985 | permira.com | London, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for PHARMAQ
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PHARMAQ
1039 people are tracked at PHARMAQ (318 in leadership, 13 in board & advisors, 708 in team); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Morten Nordstad | CEO & President | Leadership |
James Henegan | Director For Salesforce Effectiveness, Leadership Development, And Sales Tools | Leadership |
John Drinkell | Director - Business Operations Effectiveness | Leadership |
Shelly Lettman | Communications Director | Leadership |
Michael Stegemann | Executive Director | Leadership |
Marcia Brito | Head Of Transformation | Leadership |
Dori Herczegh | Director, Sr. HRBP Canada & Latam | Leadership |
Alexis Martin | Human Resources Business Partner, Enabling Functions | Leadership |
Stacey F. | Associate Director | Leadership |
Kishore Prayaga | Senior Director | Leadership |
Betty Mason | Head Of Program Management, GMS Biologics Platform | Leadership |
Alexandra Hadfield | Associate Director, Partner Communications & Digital Lead | Leadership |
Tommy Brooks | Director, Head Of Sales | Leadership |
Julian Aymans | Vice President Global External Operations | Leadership |
Darren Remsburg | Associate Director, Veterinary Medical Information & Product Support | Leadership |
Chatterjee Jaydip | Director Supply Chain & Logistics | Leadership |
Todd Odonnell | Vice President Global Transformation | Leadership |
Doug Jenkins | Head Of U.s. Pricing, Contracting, And Customer Operations | Leadership |
Tomasz Dziechciarz | Senior Director, Global Trade Compliance | Leadership |
Joseph Morrin | Central Planning & Performance Lead - Director, Global External Supply | Leadership |
1019 more people are available in the full profile.
Complete people profiles for PHARMAQ
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PHARMAQ
3 dated milestones of PHARMAQ across 20 years, from founding to its latest funding, stage changes and deals.
- Founded PHARMAQ is founded.
- Exit Acquired by Permira.
- Funding First funding round of $53K.
Web traffic of PHARMAQ
The website of PHARMAQ (pharmaq.com) receives about 5.1K visits a month.
- Monthly visits5.1K
▲ 15.7% vs previous month
Websites whose visitors overlap most with PHARMAQ. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
veiatlas.no | veiatlas.no | 100% | #4,321,295 | – | |
idexx.co.uk | idexx.co.uk | 88% | #1,165,611 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PHARMAQ
PHARMAQ was founded in 1999 and raised its 1st funding round 20 years after it was founded.
PHARMAQ is headquartered in Norway.
Morten Nordstad is the CEO of PHARMAQ, as recorded in our data.
PHARMAQ has 14 employees.
Annual revenue of PHARMAQ is $2.65M as on Nov 30, 2022.
PHARMAQ is established as a global leader in the development of vaccines and health solutions for the aquaculture industry. The company is focused on providing environmentally sound and effective products through dedicated research. Operations are centered in Norway, with subsidiaries across multiple continents including Europe, North and South America, and Asia. Solutions are tailored for various fish species such as salmonids, tilapia, and sea bass. The commitment to sustainability and innovation in fish health is supported by a workforce of approximately 420 employees.
PHARMAQ offers Vaccines and Therapeutics, Vaccination Equipment, and Diagnostics & Advice.
PHARMAQ has 2 investors. Key investors include Permira, and European Union.
PHARMAQ operates through Pharmaq As.
Yes. PHARMAQ was acquired by Permira in June 2013.